- Home
- OCTO vs HOTH Comparison
OCTO vs HOTH Comparison
Compare OCTO & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCTO
- HOTH
- Stock Information
- Founded
- OCTO 1966
- HOTH 2017
- Country
- OCTO United States
- HOTH United States
- Employees
- OCTO N/A
- HOTH N/A
- Industry
- OCTO
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- OCTO
- HOTH Health Care
- Exchange
- OCTO Nasdaq
- HOTH Nasdaq
- Market Cap
- OCTO 4.4M
- HOTH 4.9M
- IPO Year
- OCTO N/A
- HOTH 2019
- Fundamental
- Price
- OCTO $1.74
- HOTH $1.50
- Analyst Decision
- OCTO
- HOTH Strong Buy
- Analyst Count
- OCTO 0
- HOTH 4
- Target Price
- OCTO N/A
- HOTH $4.75
- AVG Volume (30 Days)
- OCTO 1.6M
- HOTH 25.5M
- Earning Date
- OCTO 11-14-2024
- HOTH 11-12-2024
- Dividend Yield
- OCTO N/A
- HOTH N/A
- EPS Growth
- OCTO N/A
- HOTH N/A
- EPS
- OCTO N/A
- HOTH N/A
- Revenue
- OCTO $39,835,256.00
- HOTH N/A
- Revenue This Year
- OCTO N/A
- HOTH N/A
- Revenue Next Year
- OCTO N/A
- HOTH N/A
- P/E Ratio
- OCTO N/A
- HOTH N/A
- Revenue Growth
- OCTO N/A
- HOTH N/A
- 52 Week Low
- OCTO $1.26
- HOTH $0.58
- 52 Week High
- OCTO $4.86
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- OCTO 49.02
- HOTH 58.81
- Support Level
- OCTO $1.56
- HOTH $1.50
- Resistance Level
- OCTO $2.22
- HOTH $1.71
- Average True Range (ATR)
- OCTO 0.27
- HOTH 0.45
- MACD
- OCTO -0.02
- HOTH 0.04
- Stochastic Oscillator
- OCTO 20.20
- HOTH 25.54
About OCTO Eightco Holdings Inc.
Eightco Holdings Inc operates in three main businesses: Forever 8 Inventory Cash Flow Solution, Web3 Business, and Packaging Business. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business. Web3 Business but has no intention of continuing this business at this time. The Packaging Business manufactures and sells custom packaging for a wide variety of products and helps customers generate brand awareness and promote brand image through packaging. The Company's two reportable segments were the Inventory Management Solutions segment and the Corrugated segment. Key revenue is generated from Inventory Management Solutions segment.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.